# Toxic epidermal necrolysis induced by axitinib in a patient with advanced lung adenocarcinoma

## TL;DR

A patient with lung cancer developed a severe skin reaction called toxic epidermal necrolysis after taking axitinib, an EGFR inhibitor.

## Contribution

Highlights a rare but serious adverse effect of axitinib in lung cancer patients.

## Key findings

- Axitinib can cause toxic epidermal necrolysis in patients with lung adenocarcinoma.
- Early recognition of widespread rash is critical for managing this adverse reaction.

## Abstract

Patients taking oral EGFR inhibitors should be alert to the risk of TEN if they suddenly develop widespread rash.